Cite

HARVARD Citation

    Dwyer, C. et al. (2017). JC virus conversion rates in natalizumab treated patients: the melbourne longitudinal cohort study. Journal of neurology, neurosurgery and psychiatry. 88 (5), p. e1. [Online]. 
  
Back to record